Home » He’s Ophthalmology: The company has been deeply engaged in ophthalmology specialist diagnosis and treatment services and optometry services for more than 20 years and has won good social recognition_ Oriental Fortune Net

He’s Ophthalmology: The company has been deeply engaged in ophthalmology specialist diagnosis and treatment services and optometry services for more than 20 years and has won good social recognition_ Oriental Fortune Net

by admin
He’s Ophthalmology: The company has been deeply engaged in ophthalmology specialist diagnosis and treatment services and optometry services for more than 20 years and has won good social recognition_ Oriental Fortune Net

  Ho’s Ophthalmology(301103) Initial public offering of shares and listing on the Growth Enterprise Market Online Roadshow was held at Panorama Roadshow on Wednesday,Ho’s OphthalmologyDirector and Deputy General Manager ZhaoGuohuaIn this roadshow, it was stated that the company has been deeply engaged in ophthalmology specialist diagnosis and treatment services and optometry services for more than 20 years, with complete subspecialty settings, strong technical force, and advocacy of medical fitting, which has won good social recognition. In view of the medical technology team,medical serviceComprehensive ability and level, medical quality status, scientific research and teaching, ShenyangHo’s OphthalmologyThe hospital has been rated as a “National Key Clinical Specialty”, and is also a “Blind Prevention and Treatment Training Base” of the National Health Commission, a training base for ophthalmologists of the International Council of Ophthalmology, and a national drug clinical trial institution. Shenyang He’s cataract surgery volume has been among the best in the Northeast region for many years; the “Reputation and Comprehensive Ranking of Chinese Hospitals” released by the Hospital Management Institute of Fudan University shows that Shenyang He’s is the Northeast region for three consecutive years from 2016 to 2018. The only private eye hospital listed on the ophthalmology reputation ranking.

ZhaoGuohuaIt also stated that in terms of diagnosis and treatment services, the medical technologies used by the company in clinical applications are all medical technologies that have been proven by clinical research and are safe and effective. The founders of the company, He Wei and He Xiangdong, are returned doctors of ophthalmology. Dr. He Wei has been focusing on the improvement of ophthalmic medical technology all the year round, and has always been active in the forefront of ophthalmic medical technology; at the same time, the company pays attention to academic exchanges and personnel training, by participating in various academic conferences at home and abroad and selecting outstanding young and middle-aged doctors to the United States Doheny ophthalmology research The Institute, the Moorfields Eye Hospital in the United Kingdom, the Kyushu University Hospital in Japan and other well-known ophthalmic institutions, keep up with the latest development of basic ophthalmic research and technology, and master the international advanced ophthalmic diagnosis and treatment technology. As a private ophthalmology hospital, Shenyang He’s Eye Hospital has been rated as a “National Key Clinical Specialty”. It is also a “Blind Prevention and Treatment Training Base” of the National Health Commission, a training base for ophthalmologists of the International Council of Ophthalmology, and a national drug clinical trial institution. In terms of optometry services, the company is an advocate and pioneer of medical optometry and optician services. By equipping professional optometrists, ophthalmologists, custom workers and high-end optometry and processing equipment, the company evaluates eye health and issues scientific optometry prescriptions. A series of professional and standardized optometry service processes, including professional inspection, eye measurement customization, and intelligent precision, ensure accurate medical fitting, safe, clear and comfortable wearing.

See also  CanSino: Recombinant Novel Coronavirus Vaccine Approved for Sequential Booster Immunization

(Article source: Panorama Network)


Article source: Panorama Network

Responsible editor: 91

original title:[路演]He’s Ophthalmology: The company has been deeply engaged in ophthalmology specialist diagnosis and treatment services and optometry services for more than 20 years, and has won good social recognition

Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.

report

Share to WeChat Moments

Open WeChat,

Click “Discover” at the bottom

Use “Sweep”

You can share the webpage to the circle of friends

Scan the QR code to follow

Oriental Fortune official website WeChat

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy